# SLNB After Neoadjuvant Treatment in Node Positive Patients

> **NCT03833960** · — · COMPLETED · sponsor: **Clinical Hospital Center Rijeka** · enrollment: 65 (actual)

## Conditions studied

- Sentinel Lymph Node Biopsy
- Locoregional Neoplasm Recurrence
- Progression, Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03833960
- **Lead sponsor:** Clinical Hospital Center Rijeka
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2019-05
- **Final completion:** 2019-06
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03833960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03833960, "SLNB After Neoadjuvant Treatment in Node Positive Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03833960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*